Cold hands on Mounjaro: what's causing it and when to act

Cold or cool hands are not listed as a common adverse effect in the Mounjaro SmPC, but are widely reported during treatment, especially early on or after a dose increase.
Reduced calorie intake lowers the body's heat output; combined with changes to circulation linked to GLP-1 activity, peripheral coolness is a plausible mechanism.
Symptoms that are severe, affect only one hand, or come with pain, skin colour changes or numbness deserve prompt medical review — they can have unrelated causes.
If cold hands are significantly affecting daily life, your prescriber can discuss options including dose timing, nutritional support and whether an investigation is appropriate.

Cold hands are a real and commonly reported experience for people on Mounjaro (tirzepatide). The sensation usually traces back to reduced peripheral blood flow as the body adjusts to treatment, and it tends to settle over time. It is not listed as a common side effect in the licensed product information, but it is well recognised among people taking GLP-1 and dual-agonist medicines. As with any new symptom that appears after starting or increasing a dose, a prescriber should know about it — especially if it is severe, one-sided, or accompanied by numbness, pain or colour changes in the fingers. Mounjaro is a prescription-only medicine, and the right person to assess whether your particular experience is expected, manageable or worth investigating further is the clinician overseeing your treatment.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Understanding cold hands on tirzepatide: the factors your prescriber will weigh up

Why Mounjaro may make your hands feel cold

When you start tirzepatide (or move up to a higher dose) several things shift in the body at once. Appetite drops, so calorie intake falls, and with fewer calories available the body produces less heat. That reduced thermal output tends to show up at the extremities first, because the body prioritises warmth at its core. This is the most straightforward explanation for the cold-hands experience many people describe in the first weeks of treatment.

There is also a circulatory dimension worth knowing about. GLP-1 receptor agonists influence vascular tone, and some researchers have noted modest changes in peripheral blood flow in people taking these medicines. Tirzepatide acts on both the GIP and GLP-1 receptors, which makes its vascular effects slightly more complex than those of a single-agonist. None of this means harm is happening, but it does explain why the sensation can feel more pronounced than you might expect from a weight-loss treatment. The tirzepatide overview on our medicines page covers how the dual-receptor mechanism works in broader terms.

For most people the feeling is bilateral (both hands equally), mild, and gradual in onset. It often peaks in the first two to four weeks after a dose change, then fades as the body adjusts. That pattern alone is reassuring, and worth tracking if you are unsure.

The decision: is this something to monitor or something to act on?

This is the real question, and the honest answer is that it depends on the full picture. Cold hands during Mounjaro treatment, when bilateral, mild and settling, generally fall into the category of an adjustment effect worth watching. Logging when it happens (time of day, which hands or fingers, whether activity or warmth helps) gives your prescriber something concrete to work from rather than a vague report.

The picture changes if any of these apply: the cold is one-sided; fingers turn white, blue or deep red; you have pain or a sharp tingling that does not resolve; or symptoms appeared with no dose change and are getting worse. Those features can point to conditions unrelated to Mounjaro entirely (Raynaud's phenomenon being the most commonly confused one) and they need a proper clinical assessment. You can read about the tingling sensation some people experience in the hands and feet alongside coldness, as the two sometimes appear together.

Separately, dehydration can amplify peripheral coldness. Nausea and reduced appetite sometimes mean people drink less than they should, and poor hydration tightens circulation further. If your fluid intake has dropped since starting treatment, that is worth addressing in its own right, and worth mentioning to your prescriber, since the NHS patient information for tirzepatide notes that staying hydrated is an important part of managing side effects.

Practical steps while you decide

You do not have to wait for a formal review to take sensible action. Layering up, keeping hands active and ensuring meals contain adequate protein and fat (not just reduced calories) can all help maintain circulation and body temperature. Some people find that spreading food intake across the day, rather than one or two small meals, reduces the dips in warmth they notice between doses.

Cold hands tend to be more noticeable on the days immediately after injection, when tirzepatide's concentration in the body is rising. Noting whether your coldest periods cluster around injection day can help confirm the connection and give your prescriber a clearer picture, and our page on Mounjaro hands goes into more detail about why the extremities are particularly affected. There is a broader discussion of feeling cold on Mounjaro more generally if the sensation extends beyond your hands.

If you are weighing up whether Mounjaro is the right treatment for you and what to expect from it physically, it is also worth reading about how Mounjaro acts on fat in the body, since understanding the mechanism can help set realistic expectations about physical changes during treatment. The cost and access context page and the treatment overview may also be useful background. And if this symptom is making you reconsider treatment altogether, that conversation is exactly what a prescriber should be having with you, not something to work through alone. At nume, a named clinician reads your consultation, not a piece of software, and aftercare is available seven days a week via our support team if something comes up between reviews.

Most people reporting cold hands on tirzepatide find it manageable and time-limited. But if yours is persistent, worsening, or just worrying you, check your eligibility and speak to our prescribers, it is a straightforward conversation and the right place to start.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions